INR 418.75
(-1.71%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5.85 Billion | 2.29 Billion | 2.63 Billion | 3.48 Billion | 1.73 Billion | 280.5 Million |
Net Income | 2.46 Billion | 1.89 Billion | 2.08 Billion | 1.42 Billion | 1.41 Billion | 1.81 Billion |
Depreciation & Amortization | 1.57 Billion | 1.54 Billion | 1.47 Billion | 1.59 Billion | 1.3 Billion | 1.11 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 2.18 Billion | -567.3 Million | 165.2 Million | 343.9 Million | -941 Million | -1.73 Billion |
Other non-cash items | 2.78 Billion | -571.1 Million | -1.09 Billion | 126.1 Million | -45.4 Million | -916.6 Million |
Investing Cash Flow | -4.48 Billion | -1.5 Billion | -2.22 Billion | -1.22 Billion | -479.8 Million | 454.4 Million |
Investments in PPE | -2.09 Billion | -1.77 Billion | -1.15 Billion | -893.6 Million | -617.4 Million | -1.49 Billion |
Acquisitions | - | -58.7 Million | 1.33 Billion | - | 432.1 Million | 21.06 Million |
Investment purchases | -2.42 Billion | -1.03 Billion | -2.87 Billion | -511.7 Million | -65.6 Million | -70.1 Million |
Sales/Maturities of investments | - | 1.09 Billion | 1.54 Billion | - | 70.1 Million | 999.7 Million |
Other Investing Activities | 39.8 Million | 269 Million | -1.06 Billion | 178.1 Million | -299 Million | 996.24 Million |
Financing Cash Flow | -774.3 Million | -785.1 Million | -1.03 Billion | -1.09 Billion | -624.6 Million | -753.1 Million |
Debt repayment | -116.3 Million | -95.1 Million | -90.9 Million | -94.5 Million | -66.7 Million | -19.3 Million |
Dividends payments | -657.9 Million | -690 Million | -946.7 Million | -1 Billion | -557.92 Million | -624.7 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -100 Thousand | -95.1 Million | -90.89 Million | -94.5 Million | -95.9 Million | -109.1 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | -8.7 Million |
Other working capital | 2.18 Billion | -567.3 Million | 165.2 Million | 343.9 Million | -941 Million | -1.72 Billion |
Cash at beginning of period | 1.89 Billion | 1.87 Billion | 2.49 Billion | 1.34 Billion | 716.4 Million | 728.4 Million |
Cash at end of period | 4.85 Billion | 1.87 Billion | 1.87 Billion | 2.5 Billion | 1.34 Billion | 710.2 Million |
Capital Expenditure | -2.09 Billion | -1.77 Billion | -1.15 Billion | -893.6 Million | -617.4 Million | -1.49 Billion |
Effect of forex changes on cash | - | - | - | -12.3 Million | - | 6.26 Million |
Net cash flow / Change in cash | 2.95 Billion | 8.6 Million | -626.3 Million | 1.16 Billion | 628.8 Million | -18.2 Million |
Free Cash Flow | 3.75 Billion | 524.7 Million | 1.48 Billion | 2.59 Billion | 1.11 Billion | -1.21 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 486.7 Million | 2.46 Billion | 775.3 Million | 621.4 Million | 681.5 Million | 383.9 Million |
Depreciation & Amortization | - | 1.57 Billion | - | 405.4 Million | 378.7 Million | 366.9 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 2.18 Billion | - | - | - | - |
Other non-cash items | -486.7 Million | 2.78 Billion | -775.3 Million | -621.4 Million | -681.5 Million | -383.9 Million |
Investing Cash Flow | - | -4.48 Billion | - | - | - | - |
Investments in PPE | - | -2.09 Billion | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | -2.42 Billion | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 39.8 Million | - | - | - | - |
Financing Cash Flow | - | -774.3 Million | - | - | - | - |
Debt repayment | - | -116.3 Million | - | - | - | - |
Dividends payments | - | -657.9 Million | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -100 Thousand | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | 2.18 Billion | - | - | - | - |
Cash at beginning of period | - | 1.89 Billion | - | 3.18 Billion | 2.42 Billion | 1.89 Billion |
Cash at end of period | - | 4.85 Billion | - | 3.99 Billion | 3.18 Billion | 2.63 Billion |
Capital Expenditure | - | -2.09 Billion | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 2.95 Billion | - | 810.8 Million | 757.4 Million | 733.8 Million |
Free Cash Flow | - | 3.75 Billion | - | 810.8 Million | 757.4 Million | 733.8 Million |
POLYMED
WYNMF
2613
ORRYY
CHI
NHI